Dana-Farber names medical director Healio ... on the evolution of therapy-related acute myeloid leukemia. Head-to-head comparison of obinutuzumab plus chlorambucil vs. rituximab plus chlorambucil in patients with chronic lymphocytic leukemia and co-existing medical conditions. VoteView Results. |
